Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Life Technologies Buys Instruments Distributor in Korea

By LabMedica International staff writers
Posted on 17 Jun 2013
Life Technologies Corp. More...
(Carlsbad, CA, USA) announced the acquisition of an instrument distributor Life Science Korea (LSK; Seoul, Republic of Korea).

LSK has been Life Technologies’' primary instrument distributor since 1994 and holds distribution rights to Applied Biosystems products, including next-generation sequencing instruments, Sanger sequencing systems, forensics, and polymerase chain reaction (PCR) products. LSK serves more than 1,000 customers in academia, government, pharmaceutical, biotech, hospitals, and applied markets. Under the acquisition terms, the LSK name will become part of Life Technologies Korea. No other terms of the deal were announced.

The combination of LSK and Life Technologies will continue to build a strong Life Technologies brand in Korea to stimulate fast and sustainable growth and be well positioned to take advantage of Korea’s focus on developing biotechnology. In the past five years, South Korea has shown solid growth in the biotechnology industry and with the Korean government's Bio-vision 2016 initiative, it is expected that the country will continue to invest heavily in the life sciences industry.

Life Technologies is a global biotechnology company with portfolio of 50,000 end-to-end solutions secured by more than 5,000 patents and licenses that span the following biologic spectrum-scientific exploration, molecular diagnostics, 21st century forensics, regenerative medicine, and agricultural research.

“The acquisition of LSK is in line with our go-direct strategy in South Korea and builds on our current capabilities and platforms in this important market,” said Mark Smedley, president of Life Technologies, Asia Pacific, Japan region. “The combination of Life Technologies Korea and LSK, bolstered by our recent acquisition of consumables distributor KDR, enables us to offer one channel to serve the many different needs of our South Korean customers and to create a superior purchasing experience.”

Related Links:
Life Technologies
Life Science Korea



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.